News From ACR 2010

Top News Stories From ACR 2010: Slideshow
TNF inhibitors may decrease risk for AD in RA, tocilizumab is rapidly effective in RA, and lupus is linked to an increased risk of cancer.

• ACR Subcutaneous Abatacept Associated With Low Immunogenicity in RA
  Medscape Medical News, November 22, 2010
• ACR Milnacipran Effective for Fibromyalgia Independent of Depression
  Medscape Medical News, November 22, 2010
• ACR Belimumab Reduces Disease Activity and Corticosteroid Use in SLE
  Medscape Medical News, November 19, 2010
• ACR TNF Inhibitors Associated With Decreased Risk for AD in RA
  Medscape Medical News, November 17, 2010
• ACR Fructose Intake Associated With an Increased Risk for Gout
  Medscape Medical News, November 16, 2010
• ACR Topical vs Oral Diclofenac: Equal Efficacy, Fewer Adverse Effects
  Medscape Medical News, November 12, 2010
• ACR Pegloticase Benefits Patients With Treatment-Refractory Gout
  Medscape Medical News, November 12, 2010
• ACR Tocilizumab Improves RA Symptoms Rapidly
  Medscape Medical News, November 12, 2010
• ACR Ibuprofen/Famotidine Reduces Gastric Ulcer Incidence
  Medscape Medical News, November 12, 2010
• ACR Modified-Release Prednisone Safe and Effective in Rheumatoid Arthritis
  Medscape Medical News, November 11, 2010
• ACR Statins May Not Benefit Kids With Lupus
  WebMD Health News, November 10, 2010
• ACR Lupus Linked to Increased Risk of Cancer
  WebMD Health News, November 10, 2010
• ACR Certolizumab Pegol Safe and Effective Over Long Term in RA
  Medscape Medical News, November 10, 2010
• ACR Denosumab Safe, Effective for Osteoporosis With Renal Impairment
  Medscape Medical News, November 10, 2010
• ACR Rilonacept Prophylactic Against Gout Flares
  Medscape Medical News, November 9, 2010
• ACR Epratuzumab Effective in Systemic Lupus Erythematosus
  Medscape Medical News, November 9, 2010
• ACR Abatacept Demonstrates Long-Term Safety in Rheumatoid Arthritis
  Medscape Medical News, November 8, 2010